Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$9.83M. The highest annual figure on record is $8.26M in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.83M | – |
| FY2024 | Dec 31, 2024 | -$7.88M | – |
| FY2023 | Dec 31, 2023 | -$7.63M | – |
| FY2022 | Dec 31, 2022 | -$10.17M | – |
| FY2021 | Dec 31, 2021 | -$12.62M | – |
| FY2020 | Dec 31, 2020 | -$14.44M | – |
| FY2019 | Dec 31, 2019 | -$12.63M | – |
| FY2018 | Dec 31, 2018 | -$6.57M | – |
| FY2017 | Dec 31, 2017 | -$4.84M | -158.6% |
| FY2016 | Dec 31, 2016 | $8.26M | +32.3% |
| FY2015 | Dec 31, 2015 | $6.24M | – |
See a number that looks wrong?